Literature DB >> 6723139

Surgical management of aggressive and malignant tumors of the proximal fibula.

M M Malawer.   

Abstract

En bloc resection of tumors of the proximal fibula by a specified route allows safe exposure of the popliteal vessels and resection of the fibula, tibiofibular joint, and adjacent musculature. Type I (marginal excision) and Type II (wide intracompartmental resection) procedures performed in ten consecutive patients were evaluated. There were five male and five female patients; the average age was 18.9 years. The histologic diagnoses were osteosarcoma (2 patients), Ewing's sarcoma (3 patients), aggressive osteoblastoma (1 patient), giant cell tumor (3 patients), and "active" osteochondroma (1 patient). All resections achieved negative margins, with no local recurrences from 14 to 37 months after operation. Pathologic specimens showed a high incidence of direct muscle infiltration. Local complications included peroneal palsy (2 patients), flap necrosis (2 patients), and synovial fistula (1 patient). No secondary surgical procedures were required. At follow-up evaluation no knees showed ligamentous instability, and ankle function was good. Selected patients with aggressive (benign) and malignant tumors of the proximal fibula can be treated successfully by resection. A good functional outcome can be anticipated.

Entities:  

Mesh:

Year:  1984        PMID: 6723139

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

1.  Case report 470. Conventional chondrosarcoma of the left fibula.

Authors:  H J Schneider; A S Weinstein
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  Surgical management of 121 benign proximal fibula tumors.

Authors:  Matthew P Abdel; Panayiotis J Papagelopoulos; Mark E Morrey; Doris E Wenger; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Proximal fibula resection in the treatment of bone tumours.

Authors:  Ralf Dieckmann; Carsten Gebert; Arne Streitbürger; Marcel-Philipp Henrichs; Uta Dirksen; Robert Rödl; Georg Gosheger; Jendrik Hardes
Journal:  Int Orthop       Date:  2011-01-11       Impact factor: 3.075

4.  Giant cell tumor of bone: risk factors for recurrence.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-08-13       Impact factor: 4.176

5.  Recurrent giant cell tumor of long bones: analysis of surgical management.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-09-16       Impact factor: 4.176

6.  Recurrent Giant Cell Tumour of Distal End Radius: Treatment and Outcomes After Further Surgeries.

Authors:  Umesh Yadav; Mohit Singla; Ajay Sheoran; Kshitij Behera; Abhishek Garg; Zile Singh Kundu; Anand Gupta; Ashish Devgun; Ravi Kumar; Puneet Yadav
Journal:  Cureus       Date:  2022-07-29

7.  Limb salvage in aggressive and malignant tumours of the fibula.

Authors:  Mayilvahanan Natarajan; M Paraskumar; G Rajkumar; A Sivaseelam; S Natarajan
Journal:  Int Orthop       Date:  2004-08-26       Impact factor: 3.075

8.  Successful treatment of aneurysmal bone cyst of the proximal fibula with embolization.

Authors:  Andreas F Mavrogenis; Giuseppe Rossi; Eugenio Rimondi; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-05-25

9.  A small-cohort study on tumor recurrence and surgery-related complications associated with proximal fibular tumors and the potential utility of biopsy.

Authors:  Tao Sun; Michal Heger; Lingxiang Wang; Mengjing Niu; Shuman Han; Xiaoran Zhang; Haitao Zhao; Wenjuan Wu
Journal:  J Clin Transl Res       Date:  2021-02-25

10.  Primary Fibular Sarcomas: Do They Behave Differently? An Institutional Review of 14 Patients.

Authors:  Manish Pruthi; Jagandeep Singh Virk; Akshay Tiwari; Gauri Kapoor; Sandeep Jain; Sunil Pasricha
Journal:  Indian J Surg Oncol       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.